No significant differences between medications for episodic migraine prophylaxis
1. In this systematic review and meta-analysis, there were no significant differences between various pharmacologic treatments for preventing episodic migraine ...
1. In this systematic review and meta-analysis, there were no significant differences between various pharmacologic treatments for preventing episodic migraine ...
1. Rimegepant significantly reduced the mean number of migraine days per month between the last 4 weeks of treatment and ...
1. In this multicenter study involving adult patients in the United States with a history of migraine, ubrogepant was shown ...
1. In this multicenter study involving adult patients in the United States with a history of migraine, ubrogepant was shown ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.